SecBot SecBot
PRESS-RELEASE ·Filed Mar 2, 2026

URGN

UroGen Pharma Ltd.
BULLISH
Impact 7/10
Horizonmonths Processed8mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▲ Bullish

The refinancing improves UroGen’s financial flexibility and reduces near-term liquidity risk. Traders should monitor utilization of the $50 million accordion feature and any updates on commercial execution or pipeline progress as potential upside catalysts.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$19.02
T+0 close · Mar 2, 2026 · via day close
Latest settled
+54.89%
T+60 · $29.46
Vs SPY
+45.56%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 2 $19.02entry
  2. T+1 · 9mo ago −1.05%α −0.14% · $18.82
  3. T+5 · 8mo ago +4.68%α +5.89% · $19.91
  4. T+20 · 8mo ago −10.62%α −2.68% · $17.00
  5. T+60 · 6mo ago +54.89%α +45.56% · $29.46
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

UroGen Pharma refinanced its debt with Pharmakon Advisors, securing a $200 million initial tranche of a $250 million senior secured term loan at a fixed 8.25% interest rate, extending repayment to 2030. The move reduces the company's cost of capital and provides non-dilutive funding to support commercial operations and pipeline development, with no financial covenants attached.

Key Financial Metrics

Deal Value
$250.0M

Key Facts

  • UroGen entered into an amended loan agreement with Pharmakon for a $250 million senior secured term loan in two tranches.
  • First tranche of $200 million funded at closing to refinance existing $125 million debt and provide additional capital.
  • Second tranche of $50 million available at UroGen’s discretion by June 30, 2027.
  • Interest fixed at 8.25%, with repayment starting Q1 2030 in four equal quarterly installments.
  • No financial covenants in the amended loan agreement.
  • Transaction strengthens balance sheet and extends maturity profile without dilution.

Financial Impact

$200 million in new capital deployed to refinance $125 million existing debt, resulting in $75 million net cash inflow; potential for additional $50 million drawdown.

debtcashFlowcostOfCapitalliquidity

Risk Factors

  • Future drawdowns could increase interest burden if not deployed efficiently.
  • Lack of financial covenants may reduce lender oversight, increasing execution risk.
  • Forward-looking statements about strategic benefits are speculative and dependent on management execution.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3247288

Track record

16 reports on URGN

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +45.68% at T+60 after the May 6, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $25.90 Now $28.10 +8.49% settles Nov 23
  2. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  3. Nov 4, 202612d ago Press Release Bearish 6/10 Entry $28.74 to $26.10 Now $28.10 +2.23% ▲ +9.19% +8.27% vs SPY
  4. Nov 2, 202614d ago Press Release Neutral 4/10 Entry $34.36 to $26.31 Now $28.10 −18.22% ▼ −23.43% −23.51% vs SPY
  5. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $33.75 to $28.74 Now $28.10 −16.74% ▼ −14.84% −14.13% vs SPY
  6. Oct 19, 202628d ago Press Release Bullish 6/10 Entry $34.15 to $34.23 Now $28.10 −17.72% ▲ +0.23% +0.38% vs SPY
  7. Oct 9, 20265w ago 144 Neutral 2/10 Entry $36.83 to $34.56 Now $28.10 −23.70% ▼ −6.16% −4.20% vs SPY
  8. Sep 9, 20269w ago Insider Cluster Neutral 2/10 Entry $45.00 to $43.04 Now $28.10 −37.56% ▼ −4.36% −4.02% vs SPY
  9. Aug 20, 202612w ago 8-K Neutral 4/10 Entry $46.80 to $45.50 Now $28.10 −39.96% ▼ −2.78% −3.89% vs SPY
  10. Aug 5, 202614w ago 8-K Bullish 7/10 Entry $46.43 to $49.00 Now $28.10 −39.48% ▲ +5.54% +5.18% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 2, 2026